Profile: Cardiogenesis Corporation is a medical device company that designs, manufactures and distributes laser-based surgical products, which promote cardiac angiogenesis. Our SoloGrip® III delivers exclusive soft tip and 360-degree tip rotation to ensure improved access to myocardium. Our solargen™ features include dual action stimuli, contact laser system, smoke evacuation not required, synchronization not required, used on beating or arrested heart, no user alignment or calibration required, permanent crystal laser medium, rapid start-up time, simple, user-friendly touchpad controls, small and lightweight - easily transported between surgical suites, and fiberoptic delivery system compatible.
The company was founded in 1989, has revenues of USD 10-25 Million, has ~30 employees and is CE certified. OTC:CGCP (SEC Filings)
8 Products/Services (Click for related suppliers)
|
• Angiogenic Therapies for the Treatment of Severe Angina |
• Coronary Angioplasty Laser Device (FDA Code: LPC) |
• Laser Revasularization Equipment |
• Laser Revasularization Equipment, CO2 |
• Laser Revasularization Equipment, Holmium YAG |
• Refrigerated Centrifuges (FDA Code: JQC / 862.2050) General purpose laboratory equipment labeled or promoted for a specific medical use is a device that is intended to prepare or examine specimens from the human body and that is labeled or promoted for a specific medical use. |
• Transmyocardial Revascularization |
• Transmyocardial Revascularization Laser System (FDA Code: MNO) |